Frequency and severity of harm of medication errors related to the parenteral nutrition process in a large university teaching hospital.

Abstract:

STUDY OBJECTIVE:To determine the frequency of medication errors, as well as the severity of harm resulting from these errors, related to the prescription, transcription, preparation, and administration of parenteral nutrition formulations. DESIGN:Prospective, observational study. SETTING:471-bed, academic teaching hospital. PATIENTS:All adult and pediatric inpatients receiving parenteral nutrition between November 1, 2002 and May 31, 2004. MEASUREMENTS AND MAIN RESULTS:The occurrence of incorrect prescribing practices, wrong formulation preparation, operational system errors, order entry errors related to automated technology, and incorrect administration practices were documented. In addition, the specific step in the drug process--prescription, transcription, preparation, and administration--at the time that the error occurred was noted. Harm scores, to assess the severity of the error in relation to the safety of the patient, were assigned based on the National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). The rate of errors with parenteral nutrition was then compared with the rate of errors with other high-alert drugs, both at our institution and at a health care consortium. A total of 4730 prescriptions for parenteral nutrition were written during the study period; 74 (1.6%) were associated with a medication error. Of these errors, 1 (1%) occurred during the prescription process (and was detected before preparation), 29 (39%) occurred during the transcription process, 18 (24%) during preparation, and 26 (35%) during the administration process. Sixty-seven (91%) of the 74 errors were considered nonharmful, as defined by NCC MERP, whereas 6 (8%) contributed to or resulted in temporary harm to a patient. The rate of errors was similar between our institution and the consortium, both for parenteral nutrition formulations and for other high-alert drugs. The overall incidence of medication errors during the study was 15.6 errors/1000 parenteral nutrition prescriptions compounded. CONCLUSION:Our results demonstrate that medication errors related to the prescription, transcription, preparation, and administration of parenteral nutrition formulations occur and occasionally result in harm. Health care institutions should develop quality assurance programs to document compliance with published safe practice guidelines for parenteral nutrition.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Sacks GS,Rough S,Kudsk KA

doi

10.1592/phco.29.8.966

subject

Has Abstract

pub_date

2009-08-01 00:00:00

pages

966-74

issue

8

eissn

0277-0008

issn

1875-9114

pii

10.1592/phco.29.8.966

journal_volume

29

pub_type

杂志文章
  • Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy.

    abstract:STUDY OBJECTIVES:To examine glycosylated hemoglobin (A1C) values longitudinally in patients who newly started metformin, sulfonylurea, or thiazolidinedione monotherapy; in a subset of patients whose A1C values were 7% or greater before starting therapy (baseline) and who achieved A1C goal (A1C < 7%) during therapy, rat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.27.8.1102

    authors: Riedel AA,Heien H,Wogen J,Plauschinat CA

    更新日期:2007-08-01 00:00:00

  • Intravenous amiodarone for conversion of atrial fibrillation: misled by meta-analysis?

    abstract::Therapeutic goals for atrial fibrillation (AF) include ventricular rate control, stroke prevention, conversion to normal sinus rhythm, and maintenance of normal sinus rhythm. The optimal strategy of rate versus rhythm control for acute management of patients with AF is a continuing debate. However, selected patients m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.8.792.36065

    authors: Slavik RS,Zed PJ

    更新日期:2004-06-01 00:00:00

  • Vigabatrin for infantile spasms.

    abstract::Infantile spasms describe a pediatric epilepsy syndrome characterized by frequent clusters of brief symmetric muscle contractions; the condition is often associated with developmental delay. When infantile spasms are accompanied by hypsarrhythmia on electroencephalogram, the condition is labeled West syndrome. The mai...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.3.298

    authors: Pesaturo KA,Spooner LM,Belliveau P

    更新日期:2011-03-01 00:00:00

  • Allopurinol for the Treatment of Refractory Aggression: A Case Series.

    abstract:OBJECTIVE:Allopurinol is a drug indicated for the treatment and prevention of gout. Through various theorized mechanisms, there has been an observed benefit in reducing aggression in patients with dementia who are refractory to traditional interventions. This case series of eight patients reports the use of allopurinol...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1943

    authors: Carr CN,Straley CM,Baugh TB

    更新日期:2017-06-01 00:00:00

  • Prevention of Clostridium difficile Infection in Critically Ill Adults.

    abstract::The incidence and severity of Clostridium difficile infection (CDI) remain high across intensive care units in the United States despite national efforts to decrease this escalating health care burden. Most published literature and guidelines address treatment rather than prevention, yet this approach may be too downs...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2200

    authors: Leedahl DD,Personett HA,Nagpal A,Barreto EF

    更新日期:2019-03-01 00:00:00

  • Optimizing pediatric dosing: a developmental pharmacologic approach.

    abstract::Many physiologic differences between children and adults can result in age-related differences in pharmacokinetics. Understanding the effects of age on bioavailability, volume of distribution, protein binding, hepatic metabolic isoenzymes, and renal elimination can provide insight into optimizing doses for pediatric p...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.29.6.680

    authors: Anderson GD,Lynn AM

    更新日期:2009-06-01 00:00:00

  • Rapid-Onset Thrombocytopenia Following Piperacillin-Tazobactam Reexposure.

    abstract::Drug-induced thrombocytopenia is a rare but serious adverse event that has been associated with multiple drugs including β-lactams. Although it mostly occurs with prolonged medication use, some cases of rapid-onset thrombocytopenia have been reported. We describe the case of a 69-year-old man who developed severe and ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1675

    authors: Nguyen VD,Tourigny JF,Roy R,Brouillette D

    更新日期:2015-12-01 00:00:00

  • Maximizing the benefit of pharmacotherapy in Parkinson's disease.

    abstract::Levodopa is one of the principal agents administered to treat patients with Parkinson's disease (PD). Several pharmacologic strategies can limit its side effects and enhance its activity. Although certain exceptions apply, dosage adjustments and drug changes should be instituted slowly. Levodopa is typically introduce...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.20.2.33s.34632

    authors: Berchou RC

    更新日期:2000-01-01 00:00:00

  • Steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients.

    abstract:STUDY OBJECTIVES:To characterize the steady-state pharmacokinetics of intravenous levetiracetam in neurocritical care patients requiring seizure prophylaxis after a neurologic injury and to determine which dosing regimens achieve serum concentrations within the recommended therapeutic range of 6-20 μg/ml. DESIGN. Prosp...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.31.10.934

    authors: Spencer DD,Jacobi J,Juenke JM,Fleck JD,Kays MB

    更新日期:2011-10-01 00:00:00

  • Treatment options for nausea and vomiting during pregnancy.

    abstract::Nausea and vomiting, common symptoms during pregnancy, often are regarded as an unpleasant but normal part of pregnancy during the first and early second trimesters. Nausea and vomiting of pregnancy (NVP) occurs in approximately 75-80% of pregnant women. The exact etiology and pathogenesis of NVP are poorly understood...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.9.1273

    authors: Badell ML,Ramin SM,Smith JA

    更新日期:2006-09-01 00:00:00

  • Pharmacokinetics of the Meropenem Component of Meropenem-Vaborbactam in the Treatment of KPC-Producing Klebsiella pneumoniae Bloodstream Infection in a Pediatric Patient.

    abstract::Meropenem-vaborbactam is a new β-lactam/β-lactamase inhibitor combination designed to target Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. Meropenem-vaborbactam was United States Food and Drug Administration-approved for complicated urinary tract infections in patients 18 years of age or olde...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.2187

    authors: Hanretty AM,Kaur I,Evangelista AT,Moore WS 2nd,Enache A,Chopra A,Cies JJ

    更新日期:2018-12-01 00:00:00

  • The future of cell therapy.

    abstract::Peripheral blood has replaced bone marrow as a source of hematopoietic stem cells for autologous rescue after high-dose chemotherapy. Patients who receive peripheral blood stem cell (PBSC) transplants experience rapid and sustained hematopoietic reconstitution. As a result, transplant-related mortality is now less tha...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Yee GC

    更新日期:1996-05-01 00:00:00

  • The promising impact of ibrutinib, a Bruton's tyrosine kinase inhibitor, for the management of lymphoid malignancies.

    abstract::Lymphoid malignancies comprise a heterogeneous group of disorders originating from clonal proliferation of B or T lymphocytes. Treatment of lymphoid neoplasms has traditionally been pursued with cytotoxic chemotherapy. To improve efficacy and ameliorate the adverse effects associated with classic chemotherapy, molecul...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1366

    authors: Bhatt V,Alejandro L,Michael A,Ganetsky A

    更新日期:2014-03-01 00:00:00

  • Respiratory tract penetration of quinolone antimicrobials: a case in study.

    abstract::Antimicrobial lung penetration is thought to be predictive of efficacy in the treatment of lower respiratory tract infections. Lung penetration studies are commonly conducted with new antimicrobial agents to elucidate their potential utility in treating such infections. Although some very useful information may emerge...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Ritrovato CA,Deeter RG

    更新日期:1991-01-01 00:00:00

  • Efficacy and safety of low-dose valganciclovir for prevention of cytomegalovirus disease in renal transplant recipients: a single-center, retrospective analysis.

    abstract:STUDY OBJECTIVE:To evaluate the safety and efficacy of valganciclovir 450 mg/day for 6 months for cytomegalovirus (CMV) prophylaxis in renal transplant recipients. DESIGN:Single-center, retrospective analysis. SETTING:Urban, academic medical center. PATIENTS:Fifty-eight patients who received de novo renal transplant...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.14.1323.43152

    authors: Gabardi S,Magee CC,Baroletti SA,Powelson JA,Cina JL,Chandraker AK

    更新日期:2004-10-01 00:00:00

  • Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis.

    abstract:STUDY OBJECTIVES:To determine the effects of atorvastatin on low-density lipoprotein cholesterol (LDL) particle size and C-reactive protein (CRP) concentrations in patients undergoing long-term hemodialysis. Another objective was to compare the effects of atorvastatin on lipoprotein profiles as determined by direct ver...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.25.3.335.61599

    authors: Dornbrook-Lavender KA,Joy MS,Denu-Ciocca CJ,Chin H,Hogan SL,Pieper JA

    更新日期:2005-03-01 00:00:00

  • Implications of cytochrome P450 2C9 polymorphism on warfarin metabolism and dosing.

    abstract::Warfarin is an anticoagulant available as a racemic mixture. The R- and S-isomers differ with respect to relative plasma concentrations, clearance, potency, sites of metabolism, and cytochrome P450 (CYP) isoenzymes responsible for metabolism. S-Warfarin, the more potent isomer, is metabolized primarily by CYP2C9. Gene...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.2.235.34106

    authors: Redman AR

    更新日期:2001-02-01 00:00:00

  • The effects of peracetic acid-hydrogen peroxide reprocessing on dialyzer solute and water permeability.

    abstract::We characterized the effects of peracetic acid-hydrogen peroxide (PAHP) reprocessing on hemodialyzer permeability to water and solutes of various molecular weights and compared these effects within and between dialyzers. An aqueous-based solution containing urea, creatinine, vancomycin, inulin, myoglobin, and albumin ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.13.1042.31587

    authors: Scott MK,Mueller BA,Sowinski KM

    更新日期:1999-09-01 00:00:00

  • Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.

    abstract::Patients with various rheumatologic and inflammatory disease states commonly require drugs known to decrease the inflammatory or autoimmune response for adequate control of their condition. Such drugs include nonsteroidal antiinflammatory drugs (NSAIDs), cyclooxygenase (COX)-2 inhibitors, corticosteroids, disease-modi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.2005.25.11.1566

    authors: Busti AJ,Hooper JS,Amaya CJ,Kazi S

    更新日期:2005-11-01 00:00:00

  • Evidence of the economic benefit of clinical pharmacy services: 1996-2000.

    abstract::We sought to summarize and assess original evaluations of the economic impact of clinical pharmacy services published from 1996-2000, and to provide recommendations and methodologic considerations for future research. A systematic literature search was conducted to identify articles that were then blinded and randomly...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.23.1.113.31910

    authors: Schumock GT,Butler MG,Meek PD,Vermeulen LC,Arondekar BV,Bauman JL,2002 Task Force on Economic Evaluation of Clinical Pharmacy Services of the American College of Clinical Pharmacy.

    更新日期:2003-01-01 00:00:00

  • Atracurium resistance in a critically Ill patient.

    abstract::A previously healthy 25-year-old man with metastatic testicular teratocarcinoma became resistant to atracurium-induced neuromuscular blockade as evidenced by train-of-four (TOF) monitoring combined with clinical assessment. Subsequently he had an adequate response with a standard dosage of pancuronium. During the firs...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Tschida SJ,Hoey LL,Nahum A,Vance-Bryan K

    更新日期:1995-07-01 00:00:00

  • Delaying the onset of type 2 diabetes mellitus in patients with prediabetes.

    abstract::The frequency of type 2 diabetes mellitus is increasing at an alarming rate. Prediabetes, also referred to as impaired glucose tolerance (IGT) and/or impaired fasting glucose, is a major risk factor for development of type 2 diabetes mellitus. In addition, IGT has been associated with an increased risk of cardiovascul...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.4.362.33170

    authors: Irons BK,Mazzolini TA,Greene RS

    更新日期:2004-03-01 00:00:00

  • Sudden hearing loss associated with tacrolimus in a kidney-pancreas allograft recipient.

    abstract::A 38-year-old woman with type 1 diabetes underwent kidney-pancreas transplantation. Her postoperative course was complicated due to recurrent acute graft rejections and pancreatitis. After initial immunosuppression with microemulsion cyclosporine, mycophenolate mofetil, and prednisone with muromonab-CD3 induction, cyc...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.10.891.31562

    authors: Min DI,Ku YM,Rayhill S,Corwin C,Wu YM,Hunsicker LG

    更新日期:1999-07-01 00:00:00

  • Discontinuation of antihypertensive drugs due to adverse events: a systematic review and meta-analysis.

    abstract::We conducted a systematic review of randomized, controlled, monotherapy trials since 1990 of oral antihypertensive agents in patients with essential hypertension. Our objective was to quantify the frequency of discontinuation of antihypertensive agents due to adverse events from a meta-analysis of the studies. A total...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,meta分析

    doi:10.1592/phco.21.11.940.34520

    authors: Ross SD,Akhras KS,Zhang S,Rozinsky M,Nalysnyk L

    更新日期:2001-08-01 00:00:00

  • Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension.

    abstract::Hypertension and diabetes appear to increase coronary heart disease risk in part by causing an abnormality in lipid metabolism. Most affected are patients with familial dyslipidemic hypertension (FDH) and noninsulin-dependent diabetes mellitus (NIDDM). The lipid disorders most often encountered in these patients are i...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: McKenney JM

    更新日期:1993-07-01 00:00:00

  • Guidelines for using darbepoetin alfa in patients with chemotherapy-induced anemia.

    abstract::Anemia is an undertreated but common complication of cancer and is associated with debilitating symptoms that impair the patient's ability to perform daily functions of life. Treatment with darbepoetin alfa, a novel erythropoiesis-stimulating protein, is appropriate for chemotherapy-induced anemia. Guidelines on darbe...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.16.110s.31970

    authors: Bloomfield M,Jaresko G,Zarek J,Dozier N

    更新日期:2003-12-01 00:00:00

  • Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the Society of Infectious Diseases Pharmacists.

    abstract::A formerly infrequently isolated strain of Clostridium difficile known as BI/NAP1 has resulted in geographically diverse outbreaks of C. difficile-associated disease. Such rapid dissemination and distribution of an outbreak strain of C. difficile are unprecedented, with many regions across North America, as well as se...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.26.3.299

    authors: Owens RC

    更新日期:2006-03-01 00:00:00

  • Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.

    abstract::Intravenous unfractionated heparin (UFH) remains an important therapeutic agent, particularly in the inpatient setting, for anticoagulation. Historically, the activated partial thromboplastin time (aPTT) has been the primary laboratory test used to monitor and adjust UFH. The aPTT test has evolved since the 1950s, and...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.2011.01049.x

    authors: Vandiver JW,Vondracek TG

    更新日期:2012-06-01 00:00:00

  • Evaluation of a Once/Day Tobramycin Regimen to Achieve Target Concentrations in Adult Patients with Cystic Fibrosis.

    abstract:STUDY OBJECTIVE:To evaluate the success of an initial tobramycin dosing regimen to achieve target peak and trough concentrations in adult patients with pulmonary exacerbations of cystic fibrosis (CF). DESIGN:Retrospective single-center medical record review. SETTING:Large tertiary care academic medical center. PATIE...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1762

    authors: Staubes BA,Metzger NL,Walker SD,Peasah SK

    更新日期:2016-06-01 00:00:00

  • Transdermal fentanyl: pharmacokinetics and preliminary clinical evaluation.

    abstract::A new transdermal drug-delivery system that administers the synthetic opioid fentanyl through intact skin was evaluated for 24 hours postoperatively in eight patients who had undergone orthopedic surgery. Plasma samples were obtained over a 72-hour period for pharmacokinetic analysis in five patients. The patients wer...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1002/j.1875-9114.1989.tb04096.x

    authors: Plezia PM,Kramer TH,Linford J,Hameroff SR

    更新日期:1989-01-01 00:00:00